Skip to main content
PLOS One logoLink to PLOS One
. 2023 Dec 15;18(12):e0295824. doi: 10.1371/journal.pone.0295824

Prevalence and predictors of magnesium imbalance among critically ill diarrheal children and their outcome in a developing country

Gazi Md Salahuddin Mamun 1, Monira Sarmin 2, Aklima Alam 2, Farzana Afroze 2, Lubaba Shahrin 2, Abu Sadat Mohammad Sayeem Bin Shahid 2, Shamsun Nahar Shaima 2, Nadia Sultana 2, Mohammod Jobayer Chisti 2,*, Tahmeed Ahmed 2
Editor: Nattachai Srisawat3
PMCID: PMC10723721  PMID: 38100423

Abstract

Despite having essential roles in maintaining human body physiology, magnesium has gained little attention. We sought to evaluate the prevalence and predictors of magnesium imbalance in diarrheal children admitted to an intensive care unit. This retrospective data analysis was conducted among children admitted between January 2019 and December 2019. Eligible children were categorized by serum magnesium levels that were extracted from the hospital database. Among 557 participants, 29 (5.2%) had hypomagnesemia, 344 (61.8%) had normomagnesemia and 184 (33.0%) had hypermagnesemia. By multivariable multinomial logistic regression, we have identified older children (adjusted multinomial odds ratio, mOR 1.01, 95% CI: 1.004–1.018, p = 0.002) as a predictor of hypomagnesemia. Conversely, younger children (adjusted mOR 0.99, 95% CI: 0.982–0.998, p = 0.02), shorter duration of fever (adjusted mOR 0.92, 95% CI: 0.857–0.996, p = 0.04), convulsion (adjusted mOR 1.55, 95% CI: 1.005–2.380, p = 0.047), dehydration (adjusted mOR 3.27, 95% CI: 2.100–5.087, p<0.001), pneumonia (adjusted mOR 2.65, 95% CI: 1.660–4.240, p<0.001) and acute kidney injury (adjusted mOR 2.70, 95% CI: 1.735–4.200, p<0.001) as the independent predictors of hypermagnesemia. The mortality was higher among children with hypermagnesemia (adjusted mOR 2.31, 95% CI: 1.26–4.25, p = 0.007). Prompt identification and management of the magnesium imbalance among critically ill diarrheal children might have survival benefits, especially in resource-limited settings.

Introduction

Magnesium is the second most abundant intracellular cation and the fourth most abundant cation overall in the human body [1]. It is very important for human health as ionized magnesium is involved in the interaction of more than 300 enzyme reactions [2]. It is essential for various functions like electrolyte homeostasis, stabilization of cell membrane, cell division, maintaining neuromuscular excitability, generation of action potentials, and cardiac function [3, 4]. Magnesium also helps immune systems in fighting against infection through the pathway of inflammatory response and production of nitric oxide [5]. Despite these important functions, magnesium homeostasis is still not always considered clinically an important risk factor against many critical bacterial infections. Thus, magnesium has been considered as “the forgotten electrolyte” [2].

Magnesium was well studied in adults. A few studies reported both hypomagnesemia and hypermagnesemia were common among critically ill children, especially with acute kidney injury, sepsis, and associated with poor outcomes [6, 7]. Diarrhea is an important public health concern, especially among lower- and middle-income countries (LMICs). Acute watery diarrhea leading to dehydration and/or acute kidney injury is an important risk factor for fluid and electrolyte imbalance [8] and is presumed to have an impact on magnesium homeostasis. However, very little is known about the prevalence and role of magnesium homeostasis in diarrheal children. So, our objective was to determine the prevalence, associated factors, and outcome of magnesium imbalance among critically ill children having diarrhea and admitted to the intensive care unit of the world’s largest diarrheal disease hospital.

Materials and methods

Study site and population

This study was operated in the Dhaka Hospital of the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b). According to the icddr,b’s annual report 2022, this largest diarrheal hospital provides care and treatment for around 200,000 patients a year. Included patients presented with diarrhea in any age or gender, with or without diarrhea-related complications or comorbidities.

Diarrhea is the entry point for admission into the hospital. Since 2009, this hospital became paperless by operating an electronic patient medical record system to keep all clinical and laboratory data. A detailed description of the Dhaka Hospital of icddr,b has been provided elsewhere [9]. The nine-bedded Intensive Care Unit (ICU) is dedicated to aiding medical care for critically ill patients presenting with respiratory distress and/or cyanosis, hypothermia, sepsis, severe sepsis, septic shock, altered mentation, convulsion, severe pneumonia with or without hypoxemia, or respiratory failure. This unit is enriched with necessary facilities for critical care management including pulse oximeter, cardiac monitors, bedside Glucometer, basic life support instruments, cardiac defibrillators, noninvasive ventilation including locally made bubble continuous positive airway pressure (bubble CPAP) oxygen therapy [10], and mechanical ventilators, etc.

Study design

This is a retrospective chart analysis conducted between 1 January 2019 and 31 December 2019. We included children less than 18 years from the intensive care unit investigated for serum total magnesium levels. Total of 594 children were tested during this study period of one year. Among them, 37 (6.2%) were excluded as they didn’t have diarrhea. The remaining 557 (93.8%) eligible children were divided into three categories according to serum magnesium level, and were included in the analysis (Fig 1).

Fig 1. Study diagram showing the procedure of selection of participants.

Fig 1

Our laboratory-generated reference value of serum magnesium reported as “Total Magnesium” was 0.65–1.05 mmol/L. Any level below the lower limit was considered as hypomagnesemia and above the higher limit was as hypermagnesemia [11].

Patient management

Evidence-based standard treatment protocols were followed during treating dehydrating diarrhea, electrolyte imbalance, and severe pneumonia [9, 1215]. Children under five presented with severe malnutrition, and diarrhea-related complications were managed according to protocolized management guidelines [12] which is consistent with the WHO [16]. Management of hypoxemia was done using low-cost and locally made bCPAP oxygen therapy [10]. Patients presented with severe dehydration received either cholera saline or normal saline at the Emergency Department and none of these fluids contained magnesium. Serum magnesium was tested after ICU admission of all the participants and none of them received any correction for magnesium imbalance before that.

In addition to these, intravenous fluid resuscitation with isotonic fluid (either Hartmann’s solution or Normal saline) was given for patients with severe sepsis. Inotropes and vasopressors were given in case of septic shock [17]. In case of non-severe patients, only a bolus dose (as mentioned above) was given. Patients were regularly followed up for any adverse reaction such as respiratory distress or flushing of face or restlessness or altered mentation, until discharge.

Measurements

A semi-structured case report form was developed and finalized for the acquisition of study-relevant data from the electronic database of icddr,b Dhaka Hospital, named Sheba. After preserving the anonymity of the patient, information on sociodemographic status (age, sex), nutritional status, and clinical characteristics on admission such as type of diarrhea, dehydration status, presence of vomiting, fever, pneumonia, respiratory distress, convulsion, sepsis, mental status, presence of hypoxemia were collected. Laboratory test results on admission such as serum sodium, potassium, chloride, bicarbonate, total calcium, total magnesium, and creatinine; treatment history including the use of antibiotics during hospital stay; and variables related to outcome (such as the number of hospital-acquired infections, ventilator support required or not, discharged or referred/left against medical advice or death during hospitalization) were recorded in the paper form.

Working definitions

Diarrhea was defined as the passage of three or more abnormally loose stools in a day [16]. Dehydration was assessed by the Dhaka method [18]. Fever was considered as the elevation of axillary temperature >38°C. Severe pneumonia and hypoxemia were defined according to the World Health Organization classification [16]. Sepsis, severe sepsis, and septic shock were defined according to surviving sepsis guideline which was adopted for diarrheal patients [17, 19]. The reference value of serum total magnesium was 0.65–1.05 mmol/L. Acute kidney injury was considered if serum creatinine level was more than 1.5 times higher than the normal age & sex-specific serum creatinine level [20].

Data analysis

All the data were entered into SPSS version 20 (IBM Corp, New York, USA) and analyzed by STATA (version SE 15.0). Clinical, socio-demographic, laboratory and other relevant data were summarized using descriptive statistics. Regarding continuous variables, means with standard deviations were used in case of normally distributed data and medians with interquartile ranges (IQRs) were used in case of skewed data. Categorical data were presented in the frequency table. In this study, a 95% confidence interval and a p-value <0.05 were considered statistically significant values. The strength of association was initially estimated by evaluating the multinomial odds ratio (mOR) by bivariate multinomial logistic regression was used to measure the strength of association and reported as multinomial odds ratio (mOR). Multivariable multinomial logistic regression analysis was done including the variables those were significant to find out the independent predictors of hypomagnesemia and hypermagnesemia compared with normal serum magnesium level.

Ethical considerations

Data were collected after the extraction of electronic medical records of children hospitalized in the intensive care unit. The information was anonymized and de-identified before analysis so the scope of getting informed written consent was waived. However, waiver of the ethical approval of hospital data disclosure for this study was obtained from the Institutional Review Board of International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b). All study procedures and methods were carried out by approved hospital guidelines that were based on the Declaration of Helsinki.

Results

During the study period, from a total of 1,507 admissions in the intensive care unit, 557 children with diarrhea (37.0%) were tested for serum total magnesium and were included in the analyses. Among them, 29 (5.2%) had hypomagnesemia, 344 (61.8%) had normomagnesemia and 184 (33.0%) had hypermagnesemia (Fig 1). With age, hypermagnesemia had an inverse relationship whereas hypomagnesemia had a linear relationship (Fig 2).

Fig 2. Distribution of serum magnesium level by age categories.

Fig 2

Here, cut-off levels for hypomagnesemia, normomagnesemia and hypermagnesemia were serum magnesium <0.65 mmol/L, 0.65–1.05 mmol/L and >1.05 mmol/L respectively.

Compared to normomagnesemia, the children with hypomagnesemia were relatively older, more likely to present with sepsis, and had fewer history of convulsion (Table 1). On the other hand, the children with hypermagnesemia were younger, presented with shorter duration of fever, dehydration, pneumonia, hypoxemia, respiratory distress, and raised serum creatinine, and fewer numbers of invasive diarrhea compared with acute watery diarrhea (Table 2). Other variables shown in Tables 1 and 2 were comparable within the groups.

Table 1. Baseline characteristics of the normomagnesemia and hypomagnesemia children admitted to ICU.

Variables Normomagnesemia (n = 344) Hypomagnesemia (n = 29) mOR1 (95% CI) P value
Age in months (median, IQR) 11 (6, 32) 31 (6, 168) 1.01 (1.01–1.02) <0.001
Sex (male) 201 (58.4) 19 (65.5) 1.35 (0.61–2.99) 0.458
Type of diarrhea
Acute watery diarrhea 227 (66.0) 19 (65.5) Reference
Invasive diarrhea 94 (27.3) 6 (20.7) 0.76 (0.30–1.97) 0.576
Persistent diarrhea 23 (6.7) 4 (13.8) 2.08 (0.65–6.63) 0.217
Duration of diarrhea in days (median, IQR) 3 (2, 5) 2 (1, 5) 1.01 (0.95–1.08) 0.766
Vomiting 171 (49.7) 20 (69.0) 2.25 (0.996–5.08) 0.051
Dehydration 93 (27.0) 6 (20.7) 0.70 (0.28–1.78) 0.459
Temperature (°C) (mean, SD) 37.6 ± 1.3 37.9 ± 1.3 1.21 (0.91–1.62) 0.198
Duration of fever in days (median, IQR) 2 (1, 4) 1 (1, 2) 0.92 (0.79–1.07) 0.265
Respiratory distress 131 (38.1) 15 (51.7) 1.74 (0.81–3.73) 0.152
Hypoxemia 88 (25.6) 9 (31.0) 1.31 (0.57–2.98) 0.521
Altered mental status 193 (56.1) 14 (48.3) 0.73 (0.34–1.56) 0.417
Pneumonia 163 (47.4) 13 (44.8) 0.90 (0.42–1.93) 0.791
Convulsion 148 (43.0) 5 (17.2) 0.28 (0.10–0.74) 0.011
Sepsis 132 (38.4) 18 (62.1) 2.63 (1.20–5.74) 0.015
Acute Kidney Injury 113 (32.9) 9 (31.0) 0.94 (0.41–2.16) 0.880

1 mOR: multinomial odds ratio

Table 2. Baseline characteristics of the normomagnesemia and hypermagnesemia children admitted to ICU.

Variables Normomagnesemia (n = 344) Hypermagnesemia (n = 184) mOR1 (95% CI) P value
Age in months (median, IQR) 11 (6, 32) 7 (4, 11) 0.98 (0.97–0.99) <0.001
Sex (male) 201 (58.4) 117 (63.6) 1.24 (0.86–1.80) 0.249
Type of diarrhea
Acute watery diarrhea 227 (66.0) 145 (78.8) Reference
Invasive diarrhea 94 (27.3) 31 (16.9) 0.52 (0.33–0.81) 0.005
Persistent diarrhea 23 (6.7) 8 (4.4) 0.54 (0.24–1.25) 0.152
Duration of diarrhea in days (median, IQR) 3 (2, 5) 3 (2, 5) 0.98 (0.94–1.02) 0.349
Vomiting 171 (49.7) 101 (54.9) 1.23 (0.86–1.76) 0.257
Dehydration 93 (27.0) 118 (64.1) 4.83 (3.29–7.08) <0.001
Temperature (°C) (mean, SD) 37.6 ± 1.3 37.6 ± 1.2 1.03 (0.90–1.19) 0.674
Duration of fever in days (median, IQR) 2 (1, 4) 2 (1, 3) 0.93 (0.87–0.99) 0.033
Respiratory distress 131 (38.1) 116 (63.0) 2.77 (1.92–4.02) <0.001
Hypoxemia (SpO2 <90% in room air) 88 (25.6) 74 (70.2) 1.96 (1.34–2.87) 0.001
Altered mental status 193 (56.1) 113 (61.4) 1.25 (0.86–1.79) 0.239
Pneumonia 163 (47.4) 131 (71.2) 2.74 (1.87–4.03) <0.001
Convulsion 148 (43.0) 89 (48.4) 1.24 (0.87–1.78) 0.240
Sepsis 132 (38.4) 69 (37.5) 0.96 (0.67–1.39) 0.844
Acute Kidney Injury 113 (32.9) 125 (67.4) 4.23 (2.86–6.25) <0.001

1 mOR: multinomial odds ratio

After excluding the inter-related variables to avoid the clinical overfitting having biological plausibility, and adjusting for potential confounders, we did multivariable multinomial logistic regression analysis with the variables significant in any bivariate analysis. We found that older children were more likely to present with hypomagnesemia. Alternately, younger children, shorter duration of fever, convulsion, dehydration, pneumonia and acute kidney injury were significantly and independently associated with hypermagnesemia (Table 3).

Table 3. Association of hypomagnesemia and hypermagnesemia with normomagnesemia by multivariable multinomial logistic regression.

Variables Hypomagnesemia (n = 29) vs Normomagnesemia (n = 344) Hypermagnesemia (n = 184) vs Normomagnesemia (n = 344)
Adjusted mOR1 (95% CI) P value Adjusted mOR (95% CI) P value
Age (months) 1.01 (1.004–1.018) 0.002 0.99 (0.982–0.998) 0.020
Duration of fever (day) 0.87 (0.726–1.053) 0.157 0.92 (0.857–0.996) 0.040
Convulsion 0.33 (0.105–1.025) 0.055 1.55 (1.005–2.380) 0.047
Dehydration 0.76 (0.254–2.272) 0.623 3.27 (2.100–5.087) <0.001
Pneumonia 1.25 (0.516–3.011) 0.625 2.65 (1.660–4.240) <0.001
Sepsis 2.20 (0.911–5.322) 0.080 0.72 (0.458–1.125) 0.148
Acute Kidney Injury 0.78 (0.309–1.961) 0.595 2.70 (1.735–4.200) <0.001

1 mOR: multinomial odds ratio

Compared to normomagnesemia, serum calcium value was found lower among children with hypomagnesemia (supplementary table 1 in S1 Table) and serum sodium, potassium, and calcium were found higher and acidosis was more prevalent among children with hypermagnesemia (supplementary table 2 in S1 Table).

Though we have not found any association in disease course and hospital outcome between normomagnesemia and hypomagnesemia (supplementary table 3 in S1 Table), ventilator support was required more for children with hypermagnesemia and their usual discharge was comparatively low compared to children having normal serum magnesium (supplementary table 4 in S1 Table). After adjusting the potential confounders among the outcome variables, these findings remain same (Table 4).

Table 4. Comparison of disease course of the hypomagnesemia and hypermagnesemia with normomagnesemia children during hospital stay.

Variables Hypomagnesemia (n = 29) vs Normomagnesemia (n = 344) Hypermagnesemia (n = 184) vs Normomagnesemia (n = 344)
mOR (95% CI) P value mOR (95% CI) P value
Ventilator support required 2.1 (0.69–6.63) 0.190 1.90 (1.04–3.48) 0.036
Duration of ICU stay (median, IQR) 1.01 (0.92–1.12) 0.793 1.02 (0.97–1.07) 0.422
Outcome- Discharge Reference Reference
LAMA1 or referred 1.95 (0.78–4.90) 0.155 2.60 (1.68–4.04) <0.001
Death 2.36 (0.74–7.53) 0.145 2.31 (1.26–4.25) 0.007

1 LAMA: left against medical advice

Discussion

To our knowledge, this is the first study that evaluated the prevalence, predictors, and outcome of magnesium imbalance in critically ill diarrheal children. This retrospective chart analysis identified the higher prevalence of hypermagnesemia than hypomagnesemia and several independent predictors. Being a younger child, having acute onset of fever, convulsion, dehydration, pneumonia, and raised creatinine were significantly and independently associated with hypermagnesemia. Similarly, hypomagnesemia was significantly associated with older children.

Our study involved critically ill diarrheal children of less than 18 years and the prevalence of hypermagnesemia in this population was 33.0% and hypomagnesemia was 5.2%. A study conducted at Dhaka Hospital of icddr,b from 2010 to 2014, found 3.6% hypomagnesemia among 139 under-five critically ill admitted children [21]. Another study conducted at the same site from 2010 to 2013 among 744 admitted diarrheal patients of ≥16 years old, disclosed that hypomagnesemia was 23.5% [22]. Though both of the findings were similar with the age variation in this study, none of the studies have shown the prevalence of hypermagnesemia. Whereas, a study in Pakistan among 179 children of one month to 15 years old, had observed 44% hypomagnesemia on admission in a pediatric intensive care unit [23]. Though another study from China among 974 septic children of 1 month to 18 years has shown that 25.3% had hypomagnesemia and 6.3% had hypermagnesemia, but the median ages were 47 and 18.7 months in these altered magnesium groups respectively [6] and this age variation also correlates with our study findings. Bandsma et al. have also found more cases of hypermagnesemia than hypomagnesemia among the malnourished children at admission in Kenya and Malawi [24]. Another study from Italy has shown that hypomagnesemia among less than 18 years old children was 9.52% whereas it was 59.01% among the elderly age group [25]. Studies have suggested that magnesium absorption is reduced in elderly age group [26], but this is yet to be confirmed among the older children. However, this might be a cause of reduced serum magnesium level among the older children.

Though the duration of fever was nearly similar to normomagnesemia group, still patient with a relatively shorter duration of fever was found an independent predictor of hypermagnesemia in our study. Even so no study was found related to the association with hypermagnesemia among children, but the aggressive illness leading to the more critical condition of the child might be a reason behind this.

However previous studies have found an association of hypomagnesemia with seizures [27, 28], we’ve not found any independent association between these. Rather, convulsion was found associated with hypermagnesemia. Studies among adult population have found that severe hypermagnesemia might causes drowsiness, hypotonia, areflexia or coma [27]. In our study, convulsion might also happen due to the coexisting of other electrolytes abnormalities from diarrhea. We have found that hypermagnesemia was also associated with hypernatraemia and studies have shown that hypernatraemia can cause convulsion [9]. So, this might be due to the combined electrolytes imbalances as another study among under-twelve years hospitalized Indian children has found no association of magnesium imbalance with seizures [29].

Study related to dehydration among diarrheal children with hypermagnesemia was not found. In our study, we have found this as an independent predictor. This might be due to excessive fluid loss from diarrhea and/or vomiting leading to volume contraction and hypermagnesemia. Similarly, dehydration might lead to more metabolic acidosis among the hypermagnesemia group. This is also reported in other studies among diarrheal children [21, 30].

We have found pneumonia as a predictor of hypermagnesemia in our study. Dabla et al. have shown that one-third of the hypermagnesemia children had pneumonia, though there was no significant association [29]. Some studies among adult pneumonia patients including SARS-CoV-2 have found that hypermagnesemia was more prevalent and ranged between 16%-54% among COVID-19 pneumonia patients [31, 32], whereas among the other hospitalized patients without pneumonia, it ranged between 5.7%-13.5% [27].

Acute kidney injury on admission was another predictor of hypermagnesemia. A recent study among 3,669 children from a pediatric-specific intensive care database has also found that hypermagnesemia was strongly associated with acute kidney injury as this altered magnesium excretion [7]. They have also found an association of hypermagnesemia with increased 28-day mortality [7]. Yue et al. have also shown a higher proportion of serum creatinine level among the children admitted in pediatric intensive care unit having higher magnesium level [28].

Though sepsis was significantly associated with hypomagnesemia in bivariate analysis, after adjusting the potential confounders, it became borderline significant. An important reason behind the association with hypomagnesemia may be due to the attribution of its immune system effect on sepsis [1]. Though there are several studies among adult sepsis patients with hypomagnesemia, this is limited among children.

Our observation of the independent association of hypocalcemia with hypomagnesemia is understandable. A study by Limaye et al. 2011 in India, stated that 69% of patients had concomitant hypocalcemia and hypomagnesemia [4]. Historically the evidence of the co-existence of hypocalcemia and hypomagnesemia is frequent [3, 29, 33]. On the other hand, hypermagnesemia was significantly associated with higher serum sodium, chloride, and calcium values along with acidosis. Similarly, a study among children has also found that hypomagnesemia and hypermagnesemia were associated with respectively lower and higher values of serum sodium, potassium, and calcium [29].

However we have not found any significant outcome difference between hypomagnesemia patients compared to normomagnesemia, but hypermagnesemia patients required more support of mechanical ventilator and significantly lower patients with hypermagnesemia were cured, survived, and discharged. Similar finding was also shared by some recent studies such as by Wang et al. among critically ill septic children, where they have mentioned that not hypomagnesemia, rather hypermagnesemia was a predictor of inpatient mortality [6]. Also, Dabla et al. have found that a higher proportion of children with hypermagnesemia needed mechanical ventilation and expired where there was no significant difference in hospital stay with altered serum magnesium levels [29]. Both of these findings are similar to us. A previous study by Broner et al. also mentioned hypermagnesemia as a predictor of high mortality in critically ill pediatric patients [34].

Limitations

This study was conducted retrospectively from the data collected during admission. Also, one-fifth of the patients had been referred to specialized hospitals due to critical conditions such as acute renal failure requiring emergency dialysis, repeated convlusions not controlled by anti-convulsants, complex congenital anomalies, etc. Their survival outcome couldn’t be analyzed in this retrospective analysis as icddr,b physicians did not follow the outcome of the referred patients. Doing a prospective study in a controlled environment could be more effective regarding the outcome of the participants.

Conclusions

The prevalence of hypomagnesemia among older children and hypermagnesemia among younger children were found to be high. Hypermagnesemia needs more attention than hypomagnesemia in children considering the poor outcome. Hypermagnesemia can be predicted by clinical presentations on admission such as younger age, shorter duration of fever, convulsion, dehydration, pneumonia, and acute kidney injury. Thus, the identification of simple clinically associated factors may help to initiate prompt management of hypermagnesemia (serum total magnesium >1.05 mmol/L) that may further help to prevent morbidity and mortality, especially in resource-limited settings.

Supporting information

S1 Checklist. STROBE statement—checklist of items that should be included in reports of case-control studies.

(DOC)

S1 Table. Supplementary tables 1 to 4.

(DOCX)

Acknowledgments

We gratefully acknowledge our core donors for their support and commitment to icddr,b’s research efforts. Current donors providing unrestricted support include the Governments of Bangladesh and Canada. We would also like to express our sincere thanks to all clinical fellows, nurses, members of the feeding team, and cleaners of the hospital for their invaluable support and contribution to patient care.

Data Availability

On the basis of recommendation of the Institutional Review Board, the Research Administration of icddr,b has imposed a restriction on disclosing any personal information of hospitalized patients as this data contain sensitive patient information. However, data generated from icddr,b’s electronic patient database can be provided to interested researchers for secondary data analyses upon approval of a Data Licensing Application & Agreement by the icddr,b Data Centre Committee. The data request may be sent to Ms. Shiblee Sayeed (shiblee_s@icddrb.org), Head, Research Administration.

Funding Statement

The authors received no specific funding for this work.

References

  • 1.Velissaris D, Karamouzos V, Pierrakos C, Aretha D, Karanikolas M. Hypomagnesemia in critically ill sepsis patients. Journal of clinical medicine research. 2015;7(12):911. doi: 10.14740/jocmr2351w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Elin RJ. Magnesium: the fifth but forgotten electrolyte. American journal of clinical pathology. 1994;102(5):616–22. doi: 10.1093/ajcp/102.5.616 [DOI] [PubMed] [Google Scholar]
  • 3.Jiang P, Lv Q, Lai T, Xu F. Does hypomagnesemia impact on the outcome of patients admitted to the intensive care unit? A systematic review and meta-analysis. Shock: Injury, Inflammation, and Sepsis: Laboratory and Clinical Approaches. 2017;47(3):288–95. [DOI] [PubMed] [Google Scholar]
  • 4.Limaye C, Londhey V, Nadkart M, Borges N. Hypomagnesemia in critically ill medical patients. J Assoc Physicians India. 2011;59(1):19–22. [PubMed] [Google Scholar]
  • 5.Thongprayoon C, Cheungpasitporn W, Erickson SB. Admission hypomagnesemia linked to septic shock in patients with systemic inflammatory response syndrome. Renal failure. 2015;37(9):1518–21. doi: 10.3109/0886022X.2015.1074519 [DOI] [PubMed] [Google Scholar]
  • 6.Wang H, Huang J, Jin X, Chen C, Zhang A, Wu Y, et al. Hypermagnesaemia, but Not Hypomagnesaemia, Is a Predictor of Inpatient Mortality in Critically Ill Children with Sepsis. Disease markers. 2022;2022. doi: 10.1155/2022/3893653 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Morooka H, Tanaka A, Kasugai D, Ozaki M, Numaguchi A, Maruyama S. Abnormal magnesium levels and their impact on death and acute kidney injury in critically ill children. Pediatric Nephrology. 2022:1–9. doi: 10.1007/s00467-021-05331-1 [DOI] [PubMed] [Google Scholar]
  • 8.Khan A, Sarker S, Alam N, Hossain M, Fuchs G, Salam M. Low osmolar oral rehydration salts solution in the treatment of acute watery diarrhoea in neonates and young infants: a randomized, controlled clinical trial. Journal of Health, Population and Nutrition. 2005:52–7. [PubMed] [Google Scholar]
  • 9.Shahrin L, Chisti MJ, Huq S, Nishath T, Christy MD, Hannan A, et al. Clinical manifestations of hyponatremia and hypernatremia in under-five diarrheal children in a diarrhea hospital. Journal of tropical pediatrics. 2016;62(3):206–12. doi: 10.1093/tropej/fmv100 [DOI] [PubMed] [Google Scholar]
  • 10.Chisti MJ, Salam MA, Smith JH, Ahmed T, Pietroni MA, Shahunja K, et al. Bubble continuous positive airway pressure for children with severe pneumonia and hypoxaemia in Bangladesh: an open, randomised controlled trial. The Lancet. 2015;386(9998):1057–65. doi: 10.1016/S0140-6736(15)60249-5 [DOI] [PubMed] [Google Scholar]
  • 11.Chisti MJ, Ahmed T, Bardhan PK, Salam MA. Evaluation of simple laboratory investigations to predict fatal outcome in infants with severe malnutrition presenting in an urban diarrhoea treatment centre in Bangladesh. Tropical Medicine & International Health. 2010;15(11):1322–5. [DOI] [PubMed] [Google Scholar]
  • 12.Ahmed T, Ali M, Ullah MM, Choudhury IA, Haque ME, Salam MA, et al. Mortality in severely malnourished children with diarrhoea and use of a standardised management protocol. The Lancet. 1999;353(9168):1919–22. doi: 10.1016/S0140-6736(98)07499-6 [DOI] [PubMed] [Google Scholar]
  • 13.Shahrin L, Chisti MJ, Shahid ASMSB, Rahman ASMMH, Islam MZ, Afroze F, et al. Injectable amoxicillin versus injectable ampicillin plus gentamicin in the treatment of severe pneumonia in children aged 2 to 59 months: protocol for an open-label randomized controlled trial. JMIR research protocols. 2020;9(11):e17735. doi: 10.2196/17735 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Mamun GMS, Sarmin M, Shahid ASMSB, Nuzhat S, Shahrin L, Afroze F, et al. Burden, predictors, and outcome of unconsciousness among under-five children hospitalized for community-acquired pneumonia: A retrospective study from a developing country. Plos one. 2023;18(6):e0287054. doi: 10.1371/journal.pone.0287054 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Mamun GMS, Zou M, Sarmin M, Brintz BJ, Rahman ASMMH, Parvin I, et al. Derivation and validation of a clinical prediction model for risk-stratification of children hospitalized with severe pneumonia in Bangladesh. PLOS Global Public Health. 2023;3(8):e0002216. doi: 10.1371/journal.pgph.0002216 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Organization WH. Pocket book of hospital care for children: guidelines for the management of common childhood illnesses: World Health Organization; 2013. [PubMed] [Google Scholar]
  • 17.Sarmin M, Ahmed T, Bardhan PK, Chisti MJ. Specialist hospital study shows that septic shock and drowsiness predict mortality in children under five with diarrhoea. Acta paediatrica. 2014;103(7):e306–e11. doi: 10.1111/apa.12640 [DOI] [PubMed] [Google Scholar]
  • 18.Chisti M, Salam M, Bardhan P, Sharifuzzaman, Ahad R, La Vincente S, et al. Influences of dehydration on clinical features of radiological pneumonia in children attending an urban diarrhoea treatment centre in Bangladesh. Annals of tropical paediatrics. 2010;30(4):311–6. doi: 10.1179/146532810X12858955921230 [DOI] [PubMed] [Google Scholar]
  • 19.Chisti MJ, Salam MA, Bardhan PK, Faruque AS, Shahid AS, Shahunja K, et al. Severe sepsis in severely malnourished young Bangladeshi children with pneumonia: a retrospective case control study. PLoS One. 2015;10(10):e0139966. doi: 10.1371/journal.pone.0139966 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Shahrin L, Sarmin M, Rahman AS, Hasnat W, Mamun GM, Shaima SN, et al. Clinical and laboratory characteristics of acute kidney injury in infants with diarrhea: a cross-sectional study in Bangladesh. Journal of International Medical Research. 2020;48(1):0300060519896913. doi: 10.1177/0300060519896913 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Sharifuzzaman, Sarmin M, Ahmed T, Alam T, Islam SB, Islam MM, et al. Determinants and outcome of metabolic acidosis in diarrheal children under 5 years of age in an urban critical care ward in Bangladesh. Global pediatric health. 2017;4:2333794X17740223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Sarmin M, Islam MM, Chisti MJ, Ahmed T, Sharmin R, Tabassum M, et al. Community acquired pneumonia among adult Bangladeshi patients hospitalized for diarrhea. Southeast Asian Journal of Tropical Medicine and Public Health. 2018;49(1):133–42. [Google Scholar]
  • 23.Saleem AF, Haque A. On admission hypomagnesemia in critically ill children: Risk factors and outcome. The Indian Journal of Pediatrics. 2009;76(12):1227–30. doi: 10.1007/s12098-009-0258-z [DOI] [PubMed] [Google Scholar]
  • 24.Bandsma RHJ, Voskuijl W, Chimwezi E, Fegan G, Briend A, Thitiri J, et al. A reduced-carbohydrate and lactose-free formulation for stabilization among hospitalized children with severe acute malnutrition: A double-blind, randomized controlled trial. PLoS Med. 2019;16(2):e1002747. Epub 2019/02/27. doi: 10.1371/journal.pmed.1002747 ; PubMed Central PMCID: PMC6390989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Catalano A, Bellone F, Chilà D, Loddo S, Morabito N, Basile G, et al. Rates of hypomagnesemia and hypermagnesemia in medical settings. Magnesium Research. 2021;34(1). doi: 10.1684/mrh.2021.0478 [DOI] [PubMed] [Google Scholar]
  • 26.Barbagallo M, Veronese N, Dominguez LJ. Magnesium in aging, health and diseases. Nutrients. 2021;13(2):463. doi: 10.3390/nu13020463 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Jahnen-Dechent W, Ketteler M. Magnesium basics. Clinical kidney journal. 2012;5(Suppl_1):i3–i14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Yue CY, Zhang CY, Huang ZL, Ying CM. A Novel U-Shaped Association Between Serum Magnesium on Admission and 28-Day In-hospital All-Cause Mortality in the Pediatric Intensive Care Unit. Frontiers in Nutrition. 2022;9. doi: 10.3389/fnut.2022.747035 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Dabla PK, Sharma S, Dabas A, Tyagi V, Agrawal S, Jhamb U, et al. Ionized blood magnesium in sick children: an overlooked electrolyte. Journal of Tropical Pediatrics. 2022;68(2):fmac022. doi: 10.1093/tropej/fmac022 [DOI] [PubMed] [Google Scholar]
  • 30.Okposio MM, Onyiriuka AN, Abhulimhen-Iyoha BI. Point-of-admission serum electrolyte profile of children less than five years old with dehydration due to acute diarrhoea. Tropical medicine and health. 2015;43(4):247–52. doi: 10.2149/tmh.2015-29 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Malinowska J, Małecka-Giełdowska M, Bańkowska D, Borecka K, Ciepiela O. Hypermagnesemia and hyperphosphatemia are highly prevalent in patients with COVID-19 and increase the risk of death. International Journal of Infectious Diseases. 2022;122:543–9. doi: 10.1016/j.ijid.2022.06.057 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Sharma R, Heidari A, Johnson RH, Advani S, Petersen G. Serum magnesium levels in hospitalized patients with SARS-CoV-2. Journal of Investigative Medicine. 2022;70(2):409–14. doi: 10.1136/jim-2021-001948 [DOI] [PubMed] [Google Scholar]
  • 33.Van Laecke S. Hypomagnesemia and hypermagnesemia. Acta Clinica Belgica. 2019;74(1):41–7. doi: 10.1080/17843286.2018.1516173 [DOI] [PubMed] [Google Scholar]
  • 34.Broner CW, Stidham GL, Westenkirchner DF, Tolley EA. Hypermagnesemia and hypocalcemia as predictors of high mortality in critically ill pediatric patients. Critical care medicine. 1990;18(9):921–8. doi: 10.1097/00003246-199009000-00004 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Nattachai Srisawat

11 Oct 2023

PONE-D-23-18444Prevalence and predictors of magnesium imbalance among critically ill diarrheal children and their outcome in a developing countryPLOS ONE

Dear Dr. Chisti,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Nov 25 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Nattachai Srisawat

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Thank you for allowing me to comment on this interesting topic.

Major concerns

1. This study well answered the prevalence of dysmagnesemia in critically ill children under 18 years of age, it did also showed that mortality was higher among patients with hypermagnesemia, however there are some more questions need to be answered. Firstly, the time point of measuring magnesium level, this was not clearly shown that ICU admission was hospital admission, so hypermagnesemia was totally caused by the patient condition or medical correction before they were transferred to ICU? This also led to the second question, hypermagnesemia could be the parameter showing that some patients were more severe than others so it showed that the hypermagnesemia related to mortality. As we all know that hypermagnesemia could be due to AKI (decreased excretion), and that would be counted as an organ failure.

2. Many factors would effect the magnesium homeostasis, that was not mentioned in this paper. E.g. older children would have lower intestinal absorption that would explain why in this study older children were found with hypomagnesemia? or the resuscitation fluids might effect the Mg level? and these could lead to the differences seen in this study?

3. In mortality associated with hypermagnesemia, I would be more satisfied to see the data on LAMA and Death of these groups, also the mOR showed interesting ratio but may be the numbers of n were too low to conclude in hypomagnesemia group. I think I would be more information to see outcomes of referred patients

Minor concerns

1. Small punctuation error on line 79.

Reviewer #2: Thank you for the opportunity to review the manuscript entitled 'Prevalence and Predictors of Magnesium Imbalance among Critically Ill Diarrheal Children and Their Outcome in a Developing Country.' In this retrospective review, the authors have highlighted the often-forgotten electrolyte, “magnesium”, and its association with diarrhea. Overall, the paper is well-written and emphasizes an intriguing aspect concerning hypermagnesemia at admission and its clinical implications. I have some comments to hopefully help improve your manuscript.

1.It is very surprising to me that hypermagnesemia has a higher prevalence than hypomagnesemia, and the prevalence of hypomagnesemia is quite low. The authors should discuss this interesting result in greater detail. Perhaps factors such as the study population, diagnostic criteria, or other factors influenced these findings. Additionally, it would be beneficial to discuss these results with those from resource-rich countries.

2.Additionally, it would be valuable to understand the mechanism by which diarrhea induces hypermagnesemia.

3.In my opinion, baseline characteristics should be included in the main manuscript and included hypomagnesemia, normomagnesemia, and hypermagnesemia groups.

4.Could you provide more details about the electrolyte imbalance abnormality that led to seizures in the study?

5.Why is metabolic acidosis more severe in the hypermagnesemia group compared to the hypomagnesemia group? How was an explanation?

6.In the conclusion, the authors should include the cut-off point for hypermagnesemia in this study. This would emphasize the need for prompt management and vigilance in this setting.

7.Moreover, in Figure 2, it would provide a clearer picture by including the cutoff points for hypermagnesemia, normomagnesemia, and hypomagnesemia.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2023 Dec 15;18(12):e0295824. doi: 10.1371/journal.pone.0295824.r002

Author response to Decision Letter 0


21 Nov 2023

Reviewer #1: Thank you for allowing me to comment on this interesting topic.

Major concerns

1. This study well answered the prevalence of dysmagnesemia in critically ill children under 18 years of age, it did also showed that mortality was higher among patients with hypermagnesemia, however there are some more questions need to be answered. Firstly, the time point of measuring magnesium level, this was not clearly shown that ICU admission was hospital admission, so hypermagnesemia was totally caused by the patient condition or medical correction before they were transferred to ICU? This also led to the second question, hypermagnesemia could be the parameter showing that some patients were more severe than others so it showed that the hypermagnesemia related to mortality. As we all know that hypermagnesemia could be due to AKI (decreased excretion), and that would be counted as an organ failure.

Response: Thank you for your valuable comments and suggestions that will definitely help to improve the quality of this manuscript.

Patients presented with severe dehydration received either cholera saline or normal saline at the Emergency Department and none of these fluids contained magnesium. Serum magnesium was tested after ICU admission of all the participants and none of them received any correction for magnesium imbalance before that. [added in line: 94-98 of track change version]

Yes, hypermagnesemia might be due to AKI and we’ve explained this under discussion with some other study findings [line: 253-258 of track change version].

2. Many factors would effect the magnesium homeostasis, that was not mentioned in this paper. E.g. older children would have lower intestinal absorption that would explain why in this study older children were found with hypomagnesemia? or the resuscitation fluids might effect the Mg level? and these could lead to the differences seen in this study?

Response: Thank you for your kind query. We have not found any specific article addressing reduced magnesium among older children. But older children might have reduced magnesium absorption as this is reduced by increasing age and this has been added (line: 222-226 of track change version). Information related to resuscitation fluid is also added (line: 94-98 of track change version) and explained under the previous response.

3. In mortality associated with hypermagnesemia, I would be more satisfied to see the data on LAMA and Death of these groups, also the mOR showed interesting ratio but may be the numbers of n were too low to conclude in hypomagnesemia group. I think I would be more information to see outcomes of referred patients

Response: Thank you for your kind suggestion. Yes, we would also be happier to share the outcomes of referred patients. But as this is a retrospective analysis and icddr,b Dhaka Hospital physicians didn’t follow the outcome of the referred patients, so we couldn’t collect the data and have mentioned this under our limitations (line: 287-289 of track change version).

Minor concerns

1. Small punctuation error on line 79.

Response: Thank you. It has been corrected now (line: 82 of track change version).

Reviewer #2: Thank you for the opportunity to review the manuscript entitled 'Prevalence and Predictors of Magnesium Imbalance among Critically Ill Diarrheal Children and Their Outcome in a Developing Country.' In this retrospective review, the authors have highlighted the often-forgotten electrolyte, “magnesium”, and its association with diarrhea. Overall, the paper is well-written and emphasizes an intriguing aspect concerning hypermagnesemia at admission and its clinical implications. I have some comments to hopefully help improve your manuscript.

Response: Thank you for kindly reviewing our manuscript and for your valuable comments. These will definitely improve the quality of our manuscript. We have addressed your comments as below:

1.It is very surprising to me that hypermagnesemia has a higher prevalence than hypomagnesemia, and the prevalence of hypomagnesemia is quite low. The authors should discuss this interesting result in greater detail. Perhaps factors such as the study population, diagnostic criteria, or other factors influenced these findings. Additionally, it would be beneficial to discuss these results with those from resource-rich countries.

Response: Thank you for your kind suggestion. The scenario here regarding the altered serum magnesium level might be due to that this study has been conducted among children. Hypomagnesemia is more common among the older population and this age variation is explained under discussion with some similar study findings including resource-rich countries (line: 208-226 of track change version).

2.Additionally, it would be valuable to understand the mechanism by which diarrhea induces hypermagnesemia.

Response: Thank you for your valuable comment. Diarrhea was present among all the participants as this study was conducted in a diarrhea hospital. So, from this study, it is not possible to compare the effect of diarrhea on the alteration of serum magnesium. As well, we do not know their baseline serum magnesium level before the diarrheal episode. However, as there were varying degrees of dehydration and acute kidney injury those were likely due to diarrhea, so we’ve mentioned their association with these factors (line: 242-244 and 253-258 of track change version).

3.In my opinion, baseline characteristics should be included in the main manuscript and included hypomagnesemia, normomagnesemia, and hypermagnesemia groups.

Response: Thank you for your opinion. Baseline characteristics tables were included in the main manuscript (Table 1 and Table 2).

4.Could you provide more details about the electrolyte imbalance abnormality that led to seizures in the study?

Response: Thank you for your query. We’ve elaborated and added other study findings regarding the association between other electrolyte imbalances that may also cause seizures (line: 237-240 of track change version).

5.Why is metabolic acidosis more severe in the hypermagnesemia group compared to the hypomagnesemia group? How was an explanation?

Response: Dehydration might lead to more metabolic acidosis by causing volume contraction among the hypermagnesemia group. Now it is explained under discussion (line: 244-246 of track change version).

6.In the conclusion, the authors should include the cut-off point for hypermagnesemia in this study. This would emphasize the need for prompt management and vigilance in this setting.

Response: Thank you for your kind suggestion. We’ve now added the cut-off point for hypermagnesemia under the conclusion (line: 298 of track change version).

7.Moreover, in Figure 2, it would provide a clearer picture by including the cutoff points for hypermagnesemia, normomagnesemia, and hypomagnesemia.

Response: Thank you for your kind suggestion. We’ve now added the cut-off points for hypermagnesemia, normomagnesemia, and hypomagnesemia in the legend of Figure 2 (line: 156-159 of track change version).

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 1

Nattachai Srisawat

29 Nov 2023

Prevalence and predictors of magnesium imbalance among critically ill diarrheal children and their outcome in a developing country

PONE-D-23-18444R1

Dear Dr. Chisti,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Nattachai Srisawat

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

The authors has adequately respond to all queries.

Reviewers' comments:

Acceptance letter

Nattachai Srisawat

5 Dec 2023

PONE-D-23-18444R1

Prevalence and predictors of magnesium imbalance among critically ill diarrheal children and their outcome in a developing country

Dear Dr. Chisti:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Nattachai Srisawat

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Checklist. STROBE statement—checklist of items that should be included in reports of case-control studies.

    (DOC)

    S1 Table. Supplementary tables 1 to 4.

    (DOCX)

    Attachment

    Submitted filename: Response to Reviewers.docx

    Data Availability Statement

    On the basis of recommendation of the Institutional Review Board, the Research Administration of icddr,b has imposed a restriction on disclosing any personal information of hospitalized patients as this data contain sensitive patient information. However, data generated from icddr,b’s electronic patient database can be provided to interested researchers for secondary data analyses upon approval of a Data Licensing Application & Agreement by the icddr,b Data Centre Committee. The data request may be sent to Ms. Shiblee Sayeed (shiblee_s@icddrb.org), Head, Research Administration.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES